Patni Rajiv
CIK 0001616200
EVP, Chief R&D OfficerDirector
Filings
7
Latest Jan 12, 2026
Issuers covered
3
Showing
7 of 7
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Patni Rajiv. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Patni Rajiv has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | 3 | Jun 6, 2025 |
| BTAI | Bioxcel Therapeutics, Inc. | 2 | Jan 12, 2026 |
| RETA | Reata Pharmaceuticals Inc | 2 | Sep 26, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|